PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Navarro, Judith ^a   Gozalbo López, Beatriz ^b   Méndez, Andrea C ^b   Dantzer, Françoise ^c   Schreiber, Valérie ^c   Martínez, Carlos ^c,d   Arana, David M ^b   Farrés, Jordi ^a   Revilla Nuin, Beatriz ^d,e   Bueno, María F ^b   Ampurdanés, Coral ^a   Galindo Campos, Miguel A ^a   Knobel, Philip A ^f   Segura Bayona, Sandra ^f   Martin Caballero, Juan ^g   Stracker, Travis H ^g   Aparicio, Pedro ^h   Del Val, Margarita ^b   Yélamos, José ^a,e  

^a HOSPITAL DEL MAR   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg   (France)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e IMIB Arrixaca   (Spain)

^f INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^g Barcelona Biomedical Research Park   (Spain)

^h UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PARP1 PROTEIN, MOUSE; PARP2 PROTEIN, MOUSE;

ANIMAL; CELL CULTURE; CELL DEATH; DEFICIENCY; DNA DAMAGE; GENETICS; IMMUNOLOGY; MOUSE; PATHOLOGY; T CELL LYMPHOMA; T LYMPHOCYTE;

ANIMALS; CELL DEATH; CELLS, CULTURED; DNA DAMAGE; LYMPHOMA, T-CELL; MICE; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; T-LYMPHOCYTES;

EID: 85012005621     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41962     Document Type: Article

References (62)

1. Rothenberg, E. V. & Taghon, T. Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601-649 (2005).
2. Grossman, Z. & Paul, W. E. Dynamic tuning of lymphocytes: physiological basis, mechanisms, and function. Annu. Rev. Immunol. 33, 677-713 (2015).
3. Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity. 29, 848-862 (2008).
4. Baek, K. H. et al. p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest. J. Leukoc. Biol. 73, 850-861 (2003).
5. Prochazkova, J. et al. DNA Repair Cofactors ATMIN and NBS1 Are Required to Suppress T Cell Activation. PLoS. Genet. 11, e1005645 (2015).
6. Yelamos, J., Farres, J., Llacuna, L., Ampurdanes, C. & Martin-Caballero, J. PARP-1 and PARP-2: New players in tumour development. Am. J. Cancer Res. 1, 328-346 (2011).
7. Daniels, C. M., Ong, S. E. & Leung, A. K. The Promise of Proteomics for the Study of ADP-Ribosylation. Mol. Cell 58, 911-924 (2015).
8. Bai, P. Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance. Mol. Cell 58, 947-958 (2015).
9. Sonnenblick, A., de, A. E., Azim, H. A., Jr. & Piccart, M. An update on PARP inhibitors-moving to the adjuvant setting. Nat. Rev. Clin. Oncol. 12, 27-41 (2015).
10. O'Connor, M. J. Targeting the DNA Damage Response in Cancer. Mol. Cell 60, 547-560 (2015).
11. Isabelle, M. et al. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome. Sci. 8, 22 (2010).
12. Troiani, S. et al. Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays. FEBS J. 278, 3676-3687 (2011).
13. Riccio, A. A., Cingolani, G. & Pascal, J. M. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage. Nucleic Acids Res. (2015).
14. Gibson, B. A. et al. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353, 45-50 (2016).
15. Dantzer, F. et al. Poly(ADP-ribose) polymerase-2 contributes to the fidelity of male meiosis I and spermiogenesis. Proc. Natl. Acad. Sci. USA 103, 14854-14859 (2006).
16. Farres, J. et al. Parp-2 is required to maintain hematopoiesis following sublethal gamma-irradiation in mice. Blood 122, 44-54 (2013).
17. Farres, J. et al. PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors. Cell Death. Differ. 22, 1144-1157 (2015).
18. Robert, I., Dantzer, F. & Reina-San-Martin, B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J. Exp. Med. 206, 1047-1056 (2009).
19. Yelamos, J. et al. PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes. EMBO J. 25, 4350-4360 (2006).
20. Nicolas, L. et al. Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice. Oncogene 29, 2877-2883 (2010).
21. Mehrotra, P. et al. Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates T(H)2 differentiation and allergic airway disease. J. Allergy Clin. Immunol. 131, 521-531 (2013).
22. Valdor, R. et al. Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells. Mol. Immunol. 45, 1863-1871 (2008).
23. Zhang, P. et al. PARP-1 regulates expression of TGF-beta receptors in T cells. Blood 122, 2224-2232 (2013).
24. Luo, X. et al. Poly(ADP-ribosyl)ation of FOXP3 Protein Mediated by PARP-1 Protein Regulates the Function of Regulatory T Cells. J. Biol. Chem. 290, 28675-28682 (2015).
25. Saenz, L. et al. Transcriptional regulation by poly(ADP-ribose) polymerase-1 during T cell activation. BMC. Genomics 9, 171 (2008).
26. Menissier de, M. J. et al. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J. 22, 2255-2263 (2003).
27. Seder, R. A. & Ahmed, R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4, 835-842 (2003).
28. Nasta, F., Laudisi, F., Sambucci, M., Rosado, M. M. & Pioli, C. Increased Foxp3+ regulatory T cells in poly(ADP-Ribose) polymerase-1 deficiency. J. Immunol. 184, 3470-3477 (2010).
29. Bosco, N., Swee, L. K., Benard, A., Ceredig, R. & Rolink, A. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation. Exp. Hematol. 38, 222-232 (2010).
30. Anderson, B. E. et al. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104, 1565-1573 (2004).
31. Prlic, M., Lefrancois, L. & Jameson, S. C. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195, F49-F52 (2002).
32. Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191-1198 (2003).
33. Hsu, F. C., Pajerowski, A. G., Nelson-Holte, M., Sundsbak, R. & Shapiro, V. S. NKAP is required for T cell maturation and acquisition of functional competency. J. Exp. Med. 208, 1291-1304 (2011).
34. Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960 (1994).
35. Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R. & Weissman, I. L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptordeficient mice. Cell 89, 1033-1041 (1997).
36. Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 41, 529-542 (2014).
37. Yuen, T. J. et al. Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response. J. Virol. 84, 10220-10229 (2010).
38. Iborra, S. et al. N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation. J. Exp. Med. 210, 1463-1479 (2013).
39. Xu, R., Johnson, A. J., Liggitt, D. & Bevan, M. J. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172, 6265-6271 (2004).
40. Fang, M., Remakus, S., Roscoe, F., Ma, X. & Sigal, L. J. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization. J. Virol. 89, 776-783 (2015).
41. Jameson, S. C. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2, 547-556 (2002).
42. Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064-1068 (1997).
43. Sinclair, C., Bains, I., Yates, A. J. & Seddon, B. Asymmetric thymocyte death underlies the CD4:CD8 T-cell ratio in the adaptive immune system. Proc. Natl. Acad. Sci. USA 110, E2905-E2914 (2013).
44. Ernst, B., Lee, D. S., Chang, J. M., Sprent, J. & Surh, C. D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 11, 173-181 (1999).
45. Rabenstein, H. et al. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. J. Immunol. 192, 3507-3517 (2014).
46. Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N. & Chen, J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192, 549-556 (2000).
47. Ghonim, M. A. et al. PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function. J. Transl. Med. 13, 225 (2015).
48. Sambucci, M. et al. Effects of PARP-1 deficiency on Th1 and Th2 cell differentiation. ScientificWorldJournal. 2013, 375024 (2013).
49. Isakov, D., Dzutsev, A., Belyakov, I. M. & Berzofsky, J. A. Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. Mucosal. Immunol. 2, 450-461 (2009).
50. Sibon, D. et al. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J. Clin. Invest 116, 974-983 (2006).
51. Choi, J. et al. Genomic landscape of cutaneous T cell lymphoma. Nat. Genet. 47, 1011-1019 (2015).
52. Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166-170 (2014).
53. Jeang, K. T., Giam, C. Z., Majone, F. & Aboud, M. Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. 279, 31991-31994 (2004).
54. Weston, V. J. et al. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood 116, 4578-4587 (2010).
55. Kubota, E. et al. Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. Cell Cycle 13, 2129-2137 (2014).
56. Williamson, C. T. et al. Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol. Med. 4, 515-527 (2012).
57. Moudry, P. et al. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity. J. Cell Biol. 212, 281-288 (2016).
58. de Murcia, J. M. et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA 94, 7303-7307 (1997).
59. Lee, P. P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 15, 763-774 (2001).
60. Masson, M. et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell Biol. 18, 3563-3571 (1998).
61. Moutaftsi, M. et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 24, 817-819 (2006).
62. Medina, F. et al. Furin-processed antigens targeted to the secretory route elicit functional TAP1/?CD8+ T lymphocytes in vivo. J. Immunol. 183, 4639-4647 (2009).